Naproxen, a non-steroidal anti-inflammatory drug (NSAID), is primarily classified under HS code 3004, which pertains to "Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or for retail sale." However, classification disputes may arise when determining whether Naproxen should be classified under HS code 3003 or 3004.
- HS Code 3003: This code covers "Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not put up in measured doses or for retail sale." If Naproxen is imported in bulk form, not packaged for retail sale, it may fall under this classification.
- HS Code 3004: This code includes "Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or for retail sale." Naproxen in tablet form, capsules, or other retail packaging is appropriately classified here.
Common misclassification errors occur when the packaging and intended use are not accurately considered, leading to incorrect duty assessments and potential customs penalties. For instance, misclassifying bulk Naproxen under HS code 3004 instead of 3003 can result in non-compliance with customs regulations. Recent rulings by the World Customs Organization (WCO) and national customs authorities emphasize the importance of correct classification based on product form and packaging.
Our data indicates that 26 different HS codes have been used for Naproxen shipments, with 74.9% classified under 30049069. This suggests a need for standardized classification practices to minimize misclassification risks and ensure compliance with international trade regulations.
